company snapshot | products | we buy | media | investors | human resources | information zone | home  
 
 
   
 

media ::

 
Business Standard - Mumbai: August 9, 1999
We are focused on being world class
The Smart Investor Interview

We will spend 40 per cent of our earnings on R&D. Our research efforts will definitely pay us in the long run.

Deepak Nitrite (DNL), the manufacturer of basic and intermediate chemicals, operates through four divisions. Its nitrite division at Nandesari, Gujarat manufactures sodium nitrite and other related products. DHL's second division, - Sahyadri Dyestuffs and Chemicals in Pune manufactures fine chemicals. Hydrogenation at Taloja, near Mumbai, manufactures a range of intermediates. And the nitro aromatic division, at Vadodara, manufactures products for dye, pharma application and additives like optical brighteners.

DNL has been consistently outperforming the industry. Its turnover has, grown from Rs 104.42 crore in 1994-95 to Rs 159.85 crore in 1998-99. Net profit has jumped to Rs 11.22 crore in 1998-99 from Rs 3.48 crore. DHL's success can be attributed to its emphasis on exports and research and development. Deepak C Mehta, managing director, spoke to Rakesh P Sharma on the major strategy changes undertaken by the company in the last few years.

Q. Could you tell us about the major shift of focus in DNL’s strategy?
Earlier, we had primarily focused on meeting domestic requirements and entering import substitution products. But in the last five to seven years, we have changed our approach to move away from intermediates, which are more close commodities, to speciality intermediates. This is because we realised that the cost of operating were high and the government would find it difficult to, reduce interest cost and energy cost. We have identified exports and technology upgradation as the two major areas of thrust.

Q. What was the major reason for getting into exports?
We looked at exports as a major thrust for two reasons. First, the domestic growth rate had slowed down. So for us to grow faster, the only alternative was exports to help us take a larger share of the World market. Secondly, import duties had started corning down and sooner or later we would have had to participate in the world market, what with global competitors coming into the India. Though our initial focus of entering' international markets was to earn foreign exchange, in the last, two to three, years, we are more focused on becoming world class producers. This is because international customers are very choosy and do not accept any mediocre source of supply.

Q. Has the export gamble paid off?
Our turnover has grown from Rs 104.42 crore in March 1995 to Rs 160 crore in March 1999. On the face of it, it may appear that there is no dramatic growth. But what really has grown significantly is the percentage of exports to our .turnover: Our exports were hardly Bs 9.33 crOre five years back. They have crossed Rs 36 crore in March 1999. This is a high growth fora-company manufacturing intermediates, and achieving such growth is not easy. Significantly; we are suppliers for some of the best players in bulk drugs and agrd in the world like BASF, Bayer, Ciba and Clariant.

Even now, we are consistently improving our performance every quarter. When we started we were doing about Rs 2.5 crore a quarter, but today we are at Rs 13 crore a quarter. Once customers sees our consistent high performance in the last three years, then their commitment towards us improves.

Q. Could you give us some instances of how you manage to place a commodity product as a     speciality product?

Earlier we were making a dye intermediate. In India, it was used in dyes for making colours for Holi or colouring turbines. Here, we found that we were competing against a number ofsmall companies. We then made an ultra-pure quality of the intermediate and targeted it at totally niche markets like electronic imaging: This was earlier dominated only by the Japanese and Germans. Both these coun- tries provided such pure quality, that no one looked at products from other countries. Through research, we develbped the same product and targeted it at some customers in the US. Over the years, a standard commodity product has been converted into a hi-tech product. '

Another instance is the otho-nitrite- chloro-benzene- which is used by pigment manufactures. In this category, international customers did not touch second class manufactures. Moreover, the customers were'so cynical that they-were not asking for 98-99 , per cent purity, but were very eager to know what was there in the one per cent impurity. In order-to enter this market we started improving our technology. We even went to our major raw material suppliers to help them improve their quality, so that we coilld stop the impurities at source. Now, we have quite a few customers for this product in Korea, Japan, Germany and US.

Q. What is your outlook for the current year?
In the first quarter ended June 1999, our turnover grew to Rs 39.68 crore from Rs 37.94 crore in the corresponding previous year. Our net profifgrew by 24 per cent to Rs 2.69 crore. Since our growth depends .upon the user industries, it is very difficult to draw any projections at the moment. But we hope to do well in the next few quarters as our investments are expected to pay off and hope to see a similar rise in net profit.

Significantly, our margins are expected to improve further as we have moved to speciali- ty chemicals frort commodities. Our exports to turnoveris expected to rise to around 27 per cent. We will continue to export one-third of our products, with the balance being sold in ' the domestic market, which is still significant.
Moreover, international markets are still in a bad shape and as every body hopes, things should improve in the next few months. During the current year, we will be spending 40 per cent our earnings on R&D and beefing up our pilot plant facilities. Our research efforts will definitely pay us in the long run.


back

community | what’s new | disclaimer | contact us | sitemap